SCHEMBL17833967

SCHEMBL17833967

CC(=O)C(C)N1C(=O)S/C(=C\C=C\c2ccco2)C1=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 16/20 0.67
▸ POLB P06746 14/20 0.67
▸ L3MBTL1 Q9Y468 14/20 0.67
▸ MEN1 O00255 14/20 0.67
▸ KMT2A Q03164 14/20 0.67
▸ RECQL P46063 13/20 0.67
▸ USP2 O75604 12/20 0.67
▸ KDM4E B2RXH2 12/20 0.67
▸ BLM P54132 10/20 0.67
▸ THRB P10828 8/20 0.67
▸ APEX1 P27695 7/20 0.67
▸ TDP1 Q9NUW8 5/20 0.67
▸ HPGD P15428 5/20 0.67
▸ NSD2 O96028 4/20 0.67
▸ PTPN22 Q9Y2R2 2/20 0.67
▸ APOBEC3A P31941 1/20 0.67
▸ PTK2B Q14289 1/20 0.67
▸ APOBEC3G Q9HC16 1/20 0.67
▸ ALDH1A1 P00352 8/20 0.61
▸ ALOX12 P18054 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17834314 0.88 MEN1 (0.63) MAPTPOLBL3MBTL1MEN1KMT2A
SCHEMBL14680229 0.76 MAPT (1.00) MAPTPOLBL3MBTL1MEN1KMT2A
SCHEMBL8172936 0.74 MAPT (0.64) MAPTPOLBL3MBTL1MEN1KMT2A
SCHEMBL19419942 0.73 MAPT (0.83) MAPTPOLBL3MBTL1MEN1KMT2A
SCHEMBL26459002 0.72 MAPT (1.00) MAPTPOLBL3MBTL1MEN1KMT2A
SCHEMBL26485785 0.71 MAPT (0.65) MAPTPOLBL3MBTL1MEN1KMT2A
SCHEMBL26458902 0.70 MAPT (1.00) MAPTPOLBL3MBTL1MEN1KMT2A
SCHEMBL14680220 0.70 MAPT (1.00) MAPTPOLBL3MBTL1MEN1KMT2A
SCHEMBL17229211 0.69 KMT2A (0.82) MAPTPOLBL3MBTL1MEN1KMT2A
SCHEMBL6886015 0.67 MAPT (0.88) MAPTPOLBL3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10017520-B2 Myc modulators and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2018-07-10 — — US disclosed
US-20160168165-A1 MYC MODULATORS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168165-A1 MYC MODULATORS AND USES THEREOF MYC, MYCBP, MYCBP2 MAPT 2226/4885POLB 2076/4885L3MBTL1 2422/4885
US-10017520-B2 Myc modulators and uses thereof MYC, MYCBP, MYCBP2 MAPT 2226/4885POLB 2076/4885L3MBTL1 2422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback